Source: PR Newswire

Press Release: OpenEye Scientific : Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform

CAMBRIDGE, Mass., and SANTA FE, N.M., Sept. 21, 2021 /PRNewswire/ -- Black Diamond Therapeutics, a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, and OpenEye Scientific, a leader in computational molecular design, today announced that...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Anthony Nicholls's photo - President & CEO of OpenEye

President & CEO

Anthony Nicholls

CEO Approval Rating

86/100

Read more